BIOCHEMICAL, NEUROPHYSIOLOGICAL, AND BEHAVIORAL-EFFECTS OF WY-45,233 AND OTHER IDENTIFIED METABOLITES OF THE ANTIDEPRESSANT VENLAFAXINE

被引:214
作者
MUTH, EA
MOYER, JA
HASKINS, JT
ANDREE, TH
HUSBANDS, GEM
机构
[1] Wyeth-Ayerst Research, Princeton, New Jersey
关键词
ANTIDEPRESSANT; ACTIVE METABOLITE; VENLAFAXINE; WY-45,030; UPTAKE INHIBITION; BETA-ADRENERGIC SUBSENSITIVITY;
D O I
10.1002/ddr.430230210
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Seven metabolites of venlafaxine, identified in several species, were examined for CNS pharmacological activity in rodents. The O-desmethyl compound Wy-45,233, which is the major metabolite in man, had the greatest preclinical activity. This metabolite exhibited an antidepressant profile (monoamine uptake blockade, reversal of reserpine hypothermia, induction of pineal beta-adrenergic subsensitivity) comparable to the parent drug, venlafaxine. This compound also inhibited serotonergic and noradrenergic firing rates like the parent compound, but with less potency. The cyclohexyl ring-hydroxylated metabolite Wy-47,877 and the N-desmethyl metabolite Wy-45,494 were also active in reserpine hypothermia, but Wy-45,494 was a weaker inhibitor of serotonin uptake and both metabolites were weaker inhibitors of norepinephrine uptake than Wy-45,233. None of the seven metabolites tested exhibited significated binding at dopamine-2, muscarinic cholinergic, alpha-1-adrenergic, histamine-1, or opiate (mu) receptors. These results suggest that Wy-45,233, the O-desmethyl metabolite of venlafaxine, is an active metabolite which retains the benign side-effect profile of venlafaxine.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 14 条
  • [11] REILLY MA, 1982, J PHARMACOL EXP THER, V222, P583
  • [12] SISENWINE SF, 1986, ACTA PHARM TOXICOL S, V5, P312
  • [13] STEINER AL, 1972, J BIOL CHEM, V247, P1106
  • [14] WOOD MD, 1981, J NEUROCHEM, V37, P795